C.diff. International Conference and Health EXPO Will Deliver Up-to-date Clostridioides difficile Data + More Nov. 6-7 In St. Louis

ST. LOUIS, Mo. — The C Diff Foundation is honored to welcome 30+ international leading topic experts from hospitals, pharma, biotech, academia, and Government agencies to deliver and discuss critical information on global healthcare-associated issues.

World Renowned C Diff Foundation Announces First Ever Appointment of Paul Feuerstadt, M.D. as Director of Medical Education

NEW PORT RICHEY, Fla. — C Diff Foundation, a one hundred percent volunteer, world renowned 501(c)(3) not-for-profit organization, has appointed nationally renowned Gastroenterologist, Dr. Paul Feuerstadt as its first Director of Medical Education.

C Diff Foundation Hosts 3rd Annual Global C.diff. Awareness 2K Walks

TEANECK, N.J. — The C Diff Foundation announced today that registration is now open for the 3rd Annual Global C.diff. Awareness 2K Walks. The events, which will take place at the Morris A. Votee Park, Teaneck, N.J., Charlestown Township Park, Phoenixville, Pa., and Sims Park, New Port Richey, Fla., will be hosted by the C Diff Foundation on Saturday, May 18, 2019 from 8 a.m. – 12 p.m.

The C Diff Foundation Has Declared an Urgent Need to Raise Clostridium difficile Infection Clinical Trial Awareness Worldwide

TAMPA, Fla. — The C Diff Foundation announced today that their organization has implemented a global campaign to raise awareness of Clostridioides difficile clinical trials, clinical studies, clinical research and observational studies evaluating interventions for C. difficile prevention, treatments, and environmental safety.

C Diff Foundation Recognizes Rebiotix CEO with 2019 ‘Above and Beyond’ Award

NEW PORT RICHEY, Fla. — The C. Diff Foundation Board of Directors announced today that the 2019 “Above and Beyond” Award will be presented to Rebiotix CEO Lee Jones in Roseville, Minnesota. The award, given to one recipient annually, is given to a person or organization that show extraordinary dedication to C. diff patient safety, advocacy, and overall drive to improve the lives of those impacted by the infection.

Leading Companies to Support C Diff Foundation 6th Annual International C.diff. Conference and Health EXPO, Nov. 8-9, Philadelphia

PHILADELPHIA, Pa. — The C Diff Foundation is honored to welcome leading companies to the 6th Annual International “C.diff. Awareness Conference and Health EXPO,” as they come together to make a global difference. These companies are dedicated to the prevention, diagnostics, treatments, environmental safety products and services focused on C.difficile infections and Healthcare-associated infections and whose role serves great importance in the C.diff. community.

6th Annual International C.diff. Conference and Health EXPO in Philadelphia PA November 8-9

PHILADELPHIA, Pa. — The C Diff Foundation is honored to welcome 20+ leading topic experts joined by Dale Gerding, MD, FACP, FIDSA, Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois and Research Physician at the Edward Hines Jr. VA Hospital and Mark Wilcox, B Med Sci, BM, BS, MD, FRCPath-, Head of Microbiology and Academic Lead of Pathology at the Leeds Teaching Hospitals (LTHT).

2nd Annual Global C.diff. Walks in US and UK to Raise Awareness on Importance of Clostridium difficile Infections Worldwide

TEANECK, N.J. — Presented by the C Diff Foundation, the 2nd Annual Global C.diff. Awareness 2K Walks will take place on Saturday, May 19 at three separate locations: Morris A. Votee Park, Teaneck, New Jersey; Sims Park, New Port Richey, Florida; and in Leicester, England. All locations will include t-shirts and resourceful educational material for all registered walkers. The U.S. locations will also include water bottles and hydration stations.

C Diff Foundation Presents Award to CutisPharma in Recognition of Contribution to C. diff. Community

NEW PORT RICHEY, Fla. — The C Diff Foundation today announced that it presented CutisPharma, Inc., its “Making a Difference” award as a special recognition of the significant contribution that CutisPharma has made to the C.diff. Community: helping the advancement of C.diff. awareness as well as expanding treatment options for C.diff. patients.

The C Diff Foundation Raises Clostridium difficile Infection (C.difficile) Clinical Trial Awareness Worldwide

TAMPA, Fla. — The C Diff Foundation announced today that their organization has implemented a global campaign to raise awareness in 2018 of Clostridium difficile infection (C.difficile) clinical trials, clinical studies, clinical research and observational studies evaluating interventions for C. difficile prevention, treatments, and environmental safety.